Monitoring the antibiotic resistance in the intensive care unit of a multidisciplinary hospital

Background. Infectious complications remain a serious post-transplant problem and make a major cause of poor outcome. Given the active development of transplant services at a regional level, the problem of infectious complications becomes increasingly important and requires monitoring of the etiological structure and level of antibiotic resistance in each hospital dealing with this problem.

The purpose was to analyze the changes over time in the structure and antimicrobial resistance of the most common pathogens in various nosology, including in patients after organ transplantation, regardless gender and age.

Material and methods. The study included 37,103 patients, of whom 8,091 (21.8%) were treated in the Intensive Care Unit (ICU) of the Vitebsk Regional Clinical Hospital (VRCH) for the period from 2015 to 2017; infectious complications after organ transplantation made 3%. The clinical samples were studied for bacteriology in the Republican Scientific and Practical Center "Infection in Surgery"; 20,280 clinical isolates were investigated.

Results. Staphylococcus aureus (20.96%) dominated in the general structure of microorganisms cultured mainly from the wound surface in thermal burns; meanwhile, in the ICU, gram-negative microflora dominated and was presented with Acinetobacter spp. (22.75%) and Pseudomonas aeruginosa (22.74%) in the majority of cases. By 2017, there had been an increase in resistant isolates of Klebsiella spp. (22.87%) and Acinetobacter spp. (23.09%) and a reduction of P. aeruginosa (13.31%) and S. aureus (18.88%) seeding. The protocol of the antibacterial therapy initiation was set up in the ICU of Vitebsk Regional Clinical Hospital, based on the obtained results demonstrating that all S. aureus isolates were sensitive to linezolid, vancomycin and teicoplanin, while P. aeruginosa was sensitive to colistin. All isolated Acinetobacter spp. were sensitive to colistin and 80% of the isolates were sensitive to sulbactam. More than 95% of K. pneumonia isolates were sensitive to colistin and tigecycline.

Conclusion. The current epidemiology is characterized by the prevalence of S. aureus (20.96%) in the overall structure of microorganisms, while Acinetobacter spp. (22.25%) and P. aeruginosa (22.74%) dominate in the ICU. Based on the microbiology study results, the protocol of antibacterial therapy initiation was established in the ICU of Vitebsk Regional Clinical Hospital. It is necessary to monitor the resistance of common microorganisms to certain antibiotics in order to develop algorithms for rational antibacterial treatment in each hospital.

1. Gulyaev V.A., Novruzbekov M.S., Chugunov A.O., et al. Risk factors for infectious complications after liver transplantation. Transplantologiya. The Russian Journal of Transplantation. 2013;(4):6–9. (In Russian).

2. Polikarpova S.V., Chepurnaya I.M., Zhilina S.V., et al. Analysis of the microflora in the modern hospital. Almanac of Clinical Medicine. 2011;(24):61–62. (In Russian).

3. Skala L.Z., Sidorenko S.V., Nekhorosheva A.G., et al. Practical aspects of modern clinical microbiology. Tver: Triada Publ., 2004. 312. (In Russian).

4. Briskin B.S. Nosocomial infection and postoperative complications from the standpoint of a surgeon. Infektsii i antimikrobnaya terapiya. 2000;2(4):124–128. (In Russian).

5. Sidorenko S.V., Tishkov V.I., Ivanov D.V., Cherkashin E.A. Resistance to carbapenems – the threat of a breakthrough "last line of defense". Clin Pharmacol Th. 2005;14(2):16–20. (In Russian).

6. Allen V.G, Mitterni L., Seah C., et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto. JAMA. 2013;309(2):163– 170. PMID:23299608 DOI:10.1001/jama.2012.176575

7. Nista Е.C., Candelli M., Zocco M.A., et al. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Am J Gastroenterol. 2006;101(9):1985–1990. PMID:16968503 DOI:10.1111/j.1572-0241.2006.00716.x

8. The concept of prevention of nosocomial infections: guidelines. Approved December 6, 1999. Moscow: Minzdrav RF Publ., 1999. Available at: http://docs.cntd.ru/document/901855056 (In Russian).

9. Sukhorukova M.V., Skleenova E.Yu., Ivanchik N.V., et al. Antimicrobial Resistance of Nosocomial Staphylococcus aureus Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012. Clinical Microbiology and Antimicrobial Chemotherapy. 2014;16(4):280–286. (In Russian).

10. Yakovlev S.V. Pseudomonas aeruginosa resistance to carbapenems: MYSTIC study lessons. Pharmateca. 2007;(8):67–70. (In Russian).

11. Barkanova O.N., Perlin D.V., Shepeleva Yu.B., et al. Infectious complications of early postoperative period in patients after kidney transplantation. Journal of VolgSMU. 2016;2(58):32–34. (In Russian).

12. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–12. PMID:19035777 DOI:10.1086/595011

13. Strategy to combat the antibiotic resistance of microorganisms. Healthcare. 2017; 10. Available at: http://www. zdrav.by/bez-razdela/krugliy_stol_1017 (In Russian).

14. Ewig S., Bauer T., Torres A. The pulmonary physician in critical care 4: Nosocomial pneumonia. Thorax. 2002;57 (4):366–371. PMID:11923560

15. Rello J., Ollendorf D.A., Oster G., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115–2122. PMID:12475855

16. Gel'fand B.R. Sepsis: current state of the problem. Infektsii i antimikrobnaya terapiya. 2001;3(3):69–70. (In Russian).

17. Shkurat M.A., Pokudina I.O., Battalov D.V. Resistance of microorganisms to antimicrobial drugs. Zhivye i biokosnye sistemy. 2014;(10):10. (In Russian).

18. Antibiotics in outpatient practice: some problems. Clin Pharmacol Th. 2000;9(2):3–5. (In Russian).

19. Beloborodov V.B. Modern approaches to the improvement of antimicrobial therapy of severe infections. Clin Pharmacol Th. 2005;14(2):10–15. (In Russian).

20. Kolomiec N.D., Tonko O.V., Serookaya T.I., et al. Microbiological methods for the study of biological material: instructions for use No. 075-0210: approved by the Deputy Minister of Health of the Republic of Belarus. Minsk; 2010. (In Russian).

21. Adamyan L.V., Kuz'min V.N., Arslanyan K.N., et al. Characteristics of antibacterial preparations application in obstetrical practice. Problem of antibiotic-resistance. Lechaschii Vrach Journal. 2015;(11):51–54. (In Russian).

22. Ilyukevich G.V., Smirnov V.M. Local microbiological monitoring and antibacterial therapy of nosocomial infections at the intensive care units. Novosti hirurgii. 2010;18(6):90–98.(In Russian).

23. Gel'fand B.R., Saltanov A.I., eds. Intensive care: national leadership. Moscow: GEHOTAR-Media Publ.; 2011, Vol. 2: 241–242. (In Russian).

24. Sukhorukova M.V., Eydel’shteyn M.V., Skleenova E.Yu., et al. Antimicrobial Resistance of Nosocomial Pseudomonas aeruginosa Isolates in Russia: Results of National Multicenter Surveillance Study "MARATHON" 2011–2012. Clinical Microbiology and Antimicrobial Chemotherapy. 2014;16(4):273–279. (In Russian).

25. Sukhorukova M.V., Eydel’shteyn M.V., Skleenova E.Yu., et al. Antimicrobial Resistance of Nosocomial Acinetobacter spp. Isolates in Russia: Results of National Multicenter Surveillance Study "MARATHON" 2011–2012. Clinical Microbiology and Antimicrobial Chemotherapy. 2014;16(4):266–272. (In Russian).